Steris Healthcare: Committed to Quality Healthcare and Pharmaceutical Excellence

 

Prednisolone Acetate Ophthalmic Suspension USP – CIPVISION PREDNISOLONE 1%

CIPVISION PREDNISOLONE 1%, from Steris Healthcare, contains Prednisolone Acetate Ophthalmic Suspension USP 1%, a prescription corticosteroid eye preparation used to manage steroid-responsive inflammation of the eye. Prednisolone acetate helps reduce inflammatory activity, including redness, swelling and irritation, when corticosteroid therapy is clinically appropriate.

Because corticosteroids can suppress local immune responses, this medicine should be used only after appropriate eye evaluation. It is particularly important not to self-treat unexplained red or painful eyes, as corticosteroids may worsen or mask certain infections.

What is CIPVISION PREDNISOLONE 1% For?

CIPVISION PREDNISOLONE 1% is intended for the treatment of steroid-responsive ocular inflammation. It may be prescribed for inflammatory conditions affecting different parts of the eye when an ophthalmologist determines that topical corticosteroid therapy is appropriate.

The active ingredient, prednisolone acetate, belongs to the corticosteroid class. By suppressing inflammatory responses in ocular tissues, it can help reduce symptoms associated with inflammation.

As this is an ophthalmic suspension, the particles can settle when the bottle remains stationary. Shake the bottle well before each application so that the medicine is evenly dispersed.

Why It's Important

Eye inflammation can have several causes, including allergies, injury, autoimmune processes and infections. A corticosteroid may be helpful for some inflammatory conditions but inappropriate for certain untreated infections.

Incorrect or prolonged use of topical ophthalmic corticosteroids may increase intraocular pressure, contribute to glaucoma or cataract formation, delay wound healing, or mask the progression of an infection. Therefore, CIPVISION PREDNISOLONE 1% should be used at the prescribed dose and for the recommended duration.

Patients undergoing prolonged treatment may require follow-up examinations, including monitoring of intraocular pressure.

Key Benefits 

What Are the Benefits of Prednisolone Acetate Ophthalmic Suspension USP?

The primary benefit of Prednisolone Acetate Ophthalmic Suspension USP is its anti-inflammatory activity in the eye.

Potential therapeutic benefits include:

• Helps reduce steroid-responsive ocular inflammation

• Helps decrease inflammation-associated redness

• Helps relieve irritation associated with ocular inflammation

• Helps reduce inflammatory swelling

• Provides topical corticosteroid treatment directly to the eye

• Can support recovery from appropriate inflammatory eye conditions when prescribed by an ophthalmologist

These benefits apply to appropriate steroid-responsive conditions and should not be interpreted as evidence that prednisolone acetate treats every cause of eye redness or irritation.

Mechanism of Action 

Prednisolone acetate is a glucocorticoid corticosteroid. After topical administration, it acts on glucocorticoid receptors within ocular tissues and modifies the expression of genes involved in the inflammatory response.

This activity reduces the production and release of several inflammatory mediators and decreases inflammatory-cell activity and vascular permeability. As a result, inflammatory signs such as redness, swelling and irritation can be reduced.

However, corticosteroids also suppress local immune activity. Consequently, they can potentially allow certain infections to worsen or make their symptoms less obvious. This explains why professional diagnosis and monitoring are important when using CIPVISION PREDNISOLONE 1%.

Side Effects 

As with other ophthalmic medicines, some patients may experience side effects. Possible effects include:

• Temporary burning or stinging after application

• Mild eye irritation

• Temporary blurred vision

• Eye discomfort

• Increased intraocular pressure, particularly with prolonged use

• Delayed wound healing

• Increased risk of secondary infection with inappropriate or prolonged corticosteroid use

Temporary blurred vision immediately after administration can occur. Patients should wait until vision becomes clear before driving or operating machinery.

Serious Side Effects 

Contact an ophthalmologist promptly if you experience:

• Severe or persistent eye pain

• Significant worsening of redness or swelling

• New or worsening vision changes

• Severe sensitivity to light

• Eye discharge or symptoms suggesting infection

• Symptoms that continue to worsen despite treatment

• Marked visual disturbances

Prolonged topical corticosteroid therapy can increase intraocular pressure and may contribute to glaucoma. Extended treatment can also increase the risk of posterior subcapsular cataract formation and delayed corneal healing. Patients receiving longer courses may require regular ophthalmic monitoring.

Available Substitute 

A substitute should not be chosen simply because another product contains prednisolone or another corticosteroid. Ophthalmic corticosteroids differ in potency, formulation, concentration and clinical indications.

Depending on the diagnosis, an ophthalmologist may prescribe another corticosteroid preparation or choose a non-steroidal treatment if corticosteroid therapy is inappropriate.

If CIPVISION PREDNISOLONE 1% is unavailable, consult a doctor or pharmacist regarding an appropriate equivalent. Do not change to another eye drop without professional advice, particularly when treating postoperative inflammation or an undiagnosed ocular condition.

Dosage Guidelines 

The appropriate dosage of Prednisolone Acetate Ophthalmic Suspension USP 1% depends on the severity and type of ocular inflammation and should be determined by the prescribing ophthalmologist.

General administration guidance includes:

1. Wash your hands before using the medicine.

2. Shake the suspension thoroughly before each use.

3. Remove the cap carefully without touching the dropper tip.

4. Tilt your head backwards and gently pull down the lower eyelid.

5. Instill the prescribed number of drops into the affected eye.

6. Avoid touching the eye, eyelids or eyelashes with the dropper tip.

7. Close the eye gently after administration.

8. Replace the cap securely.

9. Follow the prescribed frequency and treatment duration.

If you miss a dose, follow your healthcare professional's instructions. Do not apply extra drops to compensate unless specifically advised.

Patients should not extend treatment on their own simply because symptoms remain. Persistent symptoms may require reassessment of the underlying diagnosis.

Precautions & Warnings 

Before using CIPVISION PREDNISOLONE 1%, tell your ophthalmologist if you have:

• Glaucoma or increased intraocular pressure

• A current or previous eye infection

• A history of ocular herpes infection

• Recent eye surgery

• Corneal injury or thinning

• An unexplained red or painful eye

• A known allergy to prednisolone or formulation ingredients

• Any other significant eye condition

Topical corticosteroids can worsen certain viral, fungal or other infections and may delay healing. Do not use this medicine for an undiagnosed eye problem without professional evaluation.

Conclusion

CIPVISION PREDNISOLONE 1% by Steris Healthcare contains Prednisolone Acetate Ophthalmic Suspension USP 1%, a prescription corticosteroid eye medicine designed to control steroid-responsive ocular inflammation. Its active ingredient, prednisolone acetate, suppresses multiple inflammatory pathways and can help reduce redness, swelling and irritation when corticosteroid therapy is medically appropriate.

The medicine requires responsible use because ophthalmic corticosteroids can increase intraocular pressure, contribute to glaucoma or cataract formation, delay healing and potentially worsen or mask certain infections. Therefore, it should not be used for unexplained red eyes or continued beyond the prescribed duration without ophthalmic assessment.

For safe and effective use, shake CIPVISION PREDNISOLONE 1% well before each application, use only the prescribed number of drops, avoid contaminating the dropper tip and attend follow-up examinations when recommended. If eye pain, redness, discharge or vision changes become worse, seek prompt advice from an eye-care professional.